#exomes
🌏 GHGA in Singapore!

At the GA4GH National Initiatives Forum, Prof. Juliane Winkelmann presented Germany’s genomics infrastructure, highlighting GHGA’s federated data hubs and genomDE’s plans for 100,000 genomes and exomes at 28 university hospitals.

🎥 Watch: youtu.be/MShAzMQjtVs?...
National Initiatives Forum Day (September 2026)
YouTube video by GA4GH
youtu.be
October 12, 2026 at 8:56 AM
How do you build a genomics biobank during a war? Researchers in Ukraine did it: 10K exomes, 21 sites and a blueprint for resilient science in Eastern Europe. #T1D #genomics #Ukraine link.springer.com/article/10.1...
A collaborative genomics platform for type 1 diabetes in Eastern and Central Europe - Metabologia
Genomic studies of type 1 diabetes have largely concentrated on Western European and North American cohorts, leaving Eastern and Central European populations under-represented and limiting the portabi...
link.springer.com
September 29, 2026 at 3:43 PM
Spotlight:
"One Million Exomes Identify FNIP1, a Metabolic Brake"
by Nobuyuki Enzan & Satoshi Koyama

FREE till Nov. 14th at
authors.elsevier.com/a/1nr1OcQbJI...
September 25, 2026 at 8:34 PM
Most pathogenic TP53 variants in healthy blood are not inherited. In 469,391 exomes, they are somatic clones, and the risk they carry is blood cancer.

https://basebybase.com/episodes/tp53-somatic-germline-cancer-risk-biobank/

@ajhgnews.bsky.social
September 10, 2026 at 5:21 PM
They asked us whether we had variants of this gene in our collection of over 2,000 exomes from patients with pediatric-onset autoimmunity.
September 7, 2026 at 7:50 AM
Clinicians will sequence tumor exomes to identify neoantigens. mRNA of these peptide sequences will be made into a personalized vaccine to raise an adaptive immune response specific to the tumor cells, and check-point therapies will be employed to overcome tumor immune evasion.
August 20, 2026 at 6:42 PM
Explore 173,303 genomes/exomes in the Pakistan Genome Resource, pinpointing rare genetic variants for drug target breakthroughs. Fascinating! PMID:42310464, Nature 2026, @Nature https://doi.org/10.1038/s41586-026-10667-5 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
Analysis of 173,303 exomes and genomes in the Pakistan Genome Resource | Nature
Naturally occurring loss-of-function variants in human genes enable drug target discovery because they mimic pharmacological inhibition of proteins. However, the study of these genetic variants is constrained by their rarity. Sequencing of diverse populations, particularly those enriched in familial relatedness, has been postulated to promote discovery of rare genetic variants1–3. Here we present the Pakistan Genome Resource, a South Asian biobank with high familial relatedness comprising 173,303 participants, who collectively carry naturally occurring homozygous loss-of-function variants in 6,476 genes. We describe the genetic architecture of this population, associations between genes and biomarkers, the distribution of loss-of-function variants across molecular pathways, and recall-by-genotype studies of therapeutically relevant genes. The Pakistan Genome Resource expands the catalogue of human genetic variants, provides a comprehensive genetic reference resource for the Pakistani p
doi.org
August 17, 2026 at 12:00 AM
Major props to Angela Wei, our first author and grad student, who drove the project from data to discovery!
rdcu.be/epzLx #Genomics #PhDlife #Science
Investigating the sources of variable impact of pathogenic variants in monogenic metabolic conditions
Nature Communications - Here the authors investigate the underlying genetic mechanisms for pathogenic variant carrier phenotype heterogeneity using exomes and clinical phenotypes from the UK and...
rdcu.be
June 18, 2025 at 10:09 PM
🎉 Just published in Nature Communications: why carriers of the same pathogenic variant can have wildly different outcomes.
We untangle three genetic factors—variant impact (ESM1b), polygenic risk scores, and genetic interactions (epistasis).
Investigating the sources of variable impact of pathogenic variants in monogenic metabolic conditions
Nature Communications - Here the authors investigate the underlying genetic mechanisms for pathogenic variant carrier phenotype heterogeneity using exomes and clinical phenotypes from the UK and...
rdcu.be
June 18, 2025 at 10:09 PM
As the 1st Canadian hospital to join a cross-border genomics network to sequence 1.6M patient exomes, @pmresearch-uhn.bsky.social will uncover genetic risks for cancer & high cholesterol. A powerful example of research in action with potential to save lives: www.theglobeandmail.com/canada/artic...
Cancer patients to be offered genomic testing as part of a joint study with U.S. hospitals
Screening in partnership with Helix, Inc. could offer Princess Margaret Cancer Centre patients insights into hereditary health risks
www.theglobeandmail.com
November 6, 2025 at 6:33 PM
A systematic approach to detect homozygous copy number losses was applied to exome data from 2,021 Indian patients with suspected Mendelian disorders.

#genomics #ClinicalGenetics #RareDisease
Systematic analysis of homozygous autosomal copy number losses in exomes improves diagnostic yield and uncovers ultra-ra
Ultra-rare recessive disorders — homozygous copy number losses on exome · Eur J Hum Genet 2026
www.genox-veille.fr
July 3, 2026 at 1:47 PM
Next up in our cohorts and consortia series:
Epi25 – Collaborative for Large-Scale Whole Genome Sequencing in Epilepsy 🧬

🧠 Epilepsy
🥼 >30,000 sequenced exomes, helpint to untangle the complex genetic causes
🌍 Over 200 partners from 40 cohorts around the world
📌 Sarah Weckhuysen
👉 epi-25.org
July 18, 2025 at 7:39 PM
Jay Shendure: low rate of solving disease cases due in part to focus on exomes (ignores the other 99% of genome) #FOGM14
November 24, 2024 at 5:56 AM
🧬 The biobank.cy Center of Excellence in Biobanking and Biomedical Research presents its first CYPROME publication, showing that about 5% of 1,446 Cypriot exomes carry medically actionable variants, highlighting the value of population-specific genomics: buff.ly/QalBbu1

🧵 1/8
January 13, 2026 at 8:00 AM
In a development that should surprise no one, population scale exome screening finds actionable variants. 🧬 🧪
Sequencing exomes in healthy populations pays dividends
In a development that should surprise no one, population scale exome screening finds actionable variants.
www.omic.ly
April 9, 2025 at 3:02 PM
Sequencing the exomes of 1,100 patients with neurodegenerative and neuromuscular diseases: A consort… via @Pharma_BI
Sequencing the exomes of 1,100 patients with neurodegenerative and neuromuscular diseases: A consortium of 18 European and Australian institutions
Reporter: Aviva Lev-Ari, PhD, RN With $15.5M Grant, EU Consortium to Sequence 1,100 Exomes to Develop Diagnostics for Neurologic Diseases November 28, 2012 By Molika Ashford A consortium of 18 Euro…
wp.me
February 4, 2026 at 10:24 AM
You know how people will pop onto social media and go "blah blah changed my life," well this is real! I can't believe the difference in my skin. Look at yesterday's photos and look at now. Exoceuticals work! I cannot wait to see how my skin looks in a month. #skicare #exomes #exoceuticals
March 28, 2025 at 8:17 PM
Some forms of genetic variation can provide some insights, e.g., the human gene knockouts mentioned by Michel, but again, these insights depend on already having a tremendous understanding of our functional physiology: www.nature.com/articles/nat...
Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity - Nature
By sequencing the exomes of 10,503 individuals living in Pakistan, the authors identify rare predicted loss-of-function mutations that are estimated to knock out genes and correlate these mutations wi...
www.nature.com
February 4, 2026 at 6:15 AM
#WeekendRead! #LiveForever! Ji &co show @cp-cellmetabolism.bsky.social that stem cell derived exomes contain a miRA capable of block cell cycle inhibitors, allowing the proliferation of senescent cells & rejuvenating mice extending life span & physical performances! www.cell.com/cell-metabol...
Exosomal miR-302b rejuvenates aging mice by reversing the proliferative arrest of senescent cells
Bi et al. propose the Senoreverse anti-aging strategy, which aims to reverse the proliferative arrest of senescent cells. Exosomal miR-302b is identified as a Senoreverse candidate that targets the ce...
www.cell.com
January 18, 2025 at 5:17 PM
The landscape of regional missense mutational intolerance quantified from 125,748 exomes https://www.biorxiv.org/content/10.1101/2024.04.11.588920v1
The landscape of regional missense mutational intolerance quantified from 125,748 exomes https://www.biorxiv.org/content/10.1101/2024.04.11.588920v1
Missense variants can have a range of functional impacts depending on factors such as the specific a
www.biorxiv.org
April 14, 2024 at 6:32 AM
Nature research paper: Analysis of 173,303 exomes and genomes in the Pakistan Genome Resource

go.nature.com/4ve8CFE
Analysis of 173,303 exomes and genomes in the Pakistan Genome Resource - Nature
The Pakistan Genome Resource compiles biobank data from 173,303 individuals with high familial relatedness, broadening the catalogue of human genetic variation and establishing a population-specific genomic reference for Pakistan.
go.nature.com
June 22, 2026 at 10:02 AM
His lab also published in Nature Comms showing that ancestral diversity provides more leverage for finding these rare, high effect size genetic variants than sheer sample size, and demonstrated that training models on 43K multi-ancestry exomes is more predictive than using 440K
European exomes...
April 2, 2026 at 9:10 PM
For example, we found over 20,000 somatic mutations in NOTCH1 and >8,000 in TP53. For multiple genes, we find many more driver mutations than reported in >40,000 cancer exomes and genomes in the COSMIC database. 13/n
November 20, 2024 at 2:28 PM